Comparison of results of voriconazole disk diffusion testing for Candida species with results from a central reference laboratory in the ARTEMIS global antifungal surveillance program.
about
Epidemiology of invasive candidiasis: a persistent public health problemCandida guilliermondii, an opportunistic fungal pathogen with decreased susceptibility to fluconazole: geographic and temporal trends from the ARTEMIS DISK antifungal surveillance programCandida rugosa, an emerging fungal pathogen with resistance to azoles: geographic and temporal trends from the ARTEMIS DISK antifungal surveillance program.Results from the ARTEMIS DISK Global Antifungal Surveillance Study: a 6.5-year analysis of susceptibilities of Candida and other yeast species to fluconazole and voriconazole by standardized disk diffusion testing.Oropharyngeal candidiasis in the era of antiretroviral therapyCorrelation of MIC with outcome for Candida species tested against voriconazole: analysis and proposal for interpretive breakpoints.Interpretive breakpoints for fluconazole and Candida revisited: a blueprint for the future of antifungal susceptibility testingCandida guilliermondii fungemia in patients with hematologic malignanciesAzole resistance of Candida glabrata in a case of recurrent fungemiaVoriconazole in the management of nosocomial invasive fungal infections.Results from the ARTEMIS DISK Global Antifungal Surveillance study, 1997 to 2005: an 8.5-year analysis of susceptibilities of Candida species and other yeast species to fluconazole and voriconazole determined by CLSI standardized disk diffusion testMulticenter comparison of the VITEK 2 antifungal susceptibility test with the CLSI broth microdilution reference method for testing amphotericin B, flucytosine, and voriconazole against Candida sppAnalysis of ALS5 and ALS6 allelic variability in a geographically diverse collection of Candida albicans isolatesResults from the ARTEMIS DISK Global Antifungal Surveillance Study, 1997 to 2007: 10.5-year analysis of susceptibilities of noncandidal yeast species to fluconazole and voriconazole determined by CLSI standardized disk diffusion testingCandida parapsilosis: a review of its epidemiology, pathogenesis, clinical aspects, typing and antimicrobial susceptibility.Detection of neonatal unit clusters of Candida parapsilosis fungaemia by microsatellite genotyping: Results from laboratory-based sentinel surveillance, South Africa, 2009-2010.Results from the ARTEMIS DISK Global Antifungal Surveillance Study, 1997 to 2007: a 10.5-year analysis of susceptibilities of Candida Species to fluconazole and voriconazole as determined by CLSI standardized disk diffusion.Nosocomial candidiasis in Rio de Janeiro State: Distribution and fluconazole susceptibility profile.Interaction of Candida albicans cell wall Als3 protein with Streptococcus gordonii SspB adhesin promotes development of mixed-species communities.Comparison between disk diffusion and microdilution methods for determining susceptibility of clinical fungal isolates to caspofungin.Are disk diffusion and Etest methods reliable for detecting Candida glabrata and other species' susceptibility to fluconazole and voriconazole?In vitro susceptibility of a large collection of Candida Strains against fluconazole and voriconazole by using the CLSI disk diffusion assay.
P2860
Q29616758-ED0654CD-0A67-4CB5-9247-DEDF5E449A1CQ30445376-0BEEEC44-75B6-44EF-BD95-45FA88EF4D13Q30445379-B6B51C8B-22B5-4562-A137-03ED5C16D917Q30447051-B65A5027-354D-4602-AD2D-7231C5986799Q33746435-B407C9FC-FD29-45A6-A7CC-0A421BD278B0Q34431984-F8B41CC0-D444-49FF-B335-D6D7F3E101CEQ34647337-45A91BCE-AB4F-471F-BB80-D65031177074Q34719843-ECFBE38E-2ECB-434C-AFFD-D31A33C8FBA4Q35073016-7CD9C215-123E-446D-8F3D-9AE57D47ED24Q35166823-FEE4C064-CFBA-4546-8A41-338BDE3CA0D4Q35913918-2D6691D7-9194-4A6F-A172-F2B72DE44F98Q36314322-BBEB4BFB-AA91-4AF7-93B4-76DA803E263FQ36328402-7FC4FCF3-6812-46AE-BAD1-1799F0F79967Q37051529-6122474B-C8B9-4C5F-9212-0B3635A24181Q37613000-930AFC4B-4698-491A-96C9-7C3FD0740A94Q39203378-8E09A7ED-C9CE-42C9-B3F2-7F48A6AD50C6Q39899742-B13C7957-DB27-4C78-BE24-637D0E6C9A59Q41052448-167920BA-D2CC-473E-8A62-EF285C605F96Q41986685-B3AAA4A0-4E86-4916-8C94-BC7B4138D92BQ42909935-8A06CE95-7FDB-417B-8873-C60B6CD06A0EQ42946325-26C24BC1-ABFE-4E5E-B804-43ADD2617A68Q51737787-5DDEC7C1-647C-41A6-B8A7-F8A6C567B4F3
P2860
Comparison of results of voriconazole disk diffusion testing for Candida species with results from a central reference laboratory in the ARTEMIS global antifungal surveillance program.
description
2005 nî lūn-bûn
@nan
2005年の論文
@ja
2005年論文
@yue
2005年論文
@zh-hant
2005年論文
@zh-hk
2005年論文
@zh-mo
2005年論文
@zh-tw
2005年论文
@wuu
2005年论文
@zh
2005年论文
@zh-cn
name
Comparison of results of voric ...... tifungal surveillance program.
@en
Comparison of results of voric ...... tifungal surveillance program.
@nl
type
label
Comparison of results of voric ...... tifungal surveillance program.
@en
Comparison of results of voric ...... tifungal surveillance program.
@nl
prefLabel
Comparison of results of voric ...... tifungal surveillance program.
@en
Comparison of results of voric ...... tifungal surveillance program.
@nl
P2093
P2860
P1476
Comparison of results of voric ...... ntifungal surveillance program
@en
P2093
M A Pfaller
R J Hollis
S A Messer
S Tendolkar
P2860
P304
P356
10.1128/JCM.43.10.5208-5213.2005
P407
P577
2005-10-01T00:00:00Z